These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23018565)

  • 1. Macrohematuria as initial presentation in a girl with factor VIII and factor IX inhibitors associated with systemic lupus erythematosus.
    Shen CY; Fu LS; Lin HK; Han SM; Wang JD
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):e344-5. PubMed ID: 23018565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired hemophilia in a patient with systemic lupus erythematosus: a case report and literature review.
    Akahoshi M; Aizawa K; Nagano S; Inoue H; Sadanaga A; Arinobu Y; Niiro H; Nakashima H
    Mod Rheumatol; 2008; 18(5):511-5. PubMed ID: 18551353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
    Hedner U
    Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
    [No Abstract]   [Full Text] [Related]  

  • 4. A therapeutic alternative for haemophiliacs with inhibitors.
    Schulman S
    Acta Paediatr; 1992; 81(6-7):564-5. PubMed ID: 1392376
    [No Abstract]   [Full Text] [Related]  

  • 5. [Macrohaematuria post-partum: an unusual case of acquired haemophilia after pregnancy].
    Prencipe MA; D'Errico M; Di Giorgio G; Gatta G; Gesuete A; Nobile M; Stallone C
    G Ital Nefrol; 2002; 19(2):204-8. PubMed ID: 12195420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant clotting factors in the treatment of hemophilia.
    Lee C
    Thromb Haemost; 1999 Aug; 82(2):516-24. PubMed ID: 10605745
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors.
    Abshire T; Kenet G
    Haemophilia; 2008 Sep; 14(5):898-902. PubMed ID: 18684126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired haemophilia A in a woman with autoimmune hepatitis and systemic lupus erythematosus: review of literature.
    Rezaieyazdi Z; Sharifi-Doloui D; Hashemzadeh K; Shirdel A; Mansouritorghabeh H
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):738-41. PubMed ID: 21885954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based use of recombinant FVIIa (NovoSeven, NiaStase) for the treatment of hemophilia with inhibitors in children and adolescents.
    Goldstein B; Geldziler B; Bjerre J; Seremetis S
    Transfus Apher Sci; 2008 Feb; 38(1):25-32. PubMed ID: 18267372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired Hemophilia as Initial Presentation in a Patient with Systemic Lupus Erythematosus.
    Khodamoradi Z; Nazarinia MA; Bazdar S
    Curr Rheumatol Rev; 2017; 13(3):236-238. PubMed ID: 28523993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching haemophilia products and inhibitor risk: a United States' perspective.
    Nance D; Rodgers GM
    Eur J Haematol; 2015 Apr; 94(4):283. PubMed ID: 25800968
    [No Abstract]   [Full Text] [Related]  

  • 13. A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors.
    Chuansumrit A; Sri-Udomporn N; Srimuninnimit V; Juntarukha R
    Haemophilia; 2001 Sep; 7(5):532-4. PubMed ID: 11554948
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
    Collins PW; Chalmers E; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Hay CR;
    Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
    [No Abstract]   [Full Text] [Related]  

  • 15. The management of hemophilia patients with inhibitors.
    Nilsson IM
    Transfus Med Rev; 1992 Oct; 6(4):285-93. PubMed ID: 1421831
    [No Abstract]   [Full Text] [Related]  

  • 16. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.
    Valentino LA; Cooper DL; Goldstein B
    Haemophilia; 2011 Jul; 17(4):579-89. PubMed ID: 21294815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired a haemophilia: a case report.
    Cinotti E; Trovato E; Fimiani M; Rubegni P
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):e106-e107. PubMed ID: 28924993
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg⁻¹) rFVIIa doses across clinical trials and registries.
    Shapiro AD; Neufeld EJ; Blanchette V; Salaj P; Gut RZ; Cooper DL
    Haemophilia; 2014 Jan; 20(1):e23-31. PubMed ID: 24354484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired hemophilia A in a woman with systemic lupus erythematosus: A case report and review of literature.
    Shen P; Li J; Tu S; Chen G; Chen C
    Medicine (Baltimore); 2020 Oct; 99(43):e22926. PubMed ID: 33120848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.